Nasus Pharma Ltd (NSRX) insider trading
Every open-market stock purchase and sale by Nasus Pharma Ltd executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Dan Benjamin Teleman (CEO), $20.3K, 4 months ago.
Last 12 months: insiders bought $61.8K (3 buys) and sold $0 (0 sales).
Recent NSRX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 17, 2026 | Dan Benjamin Teleman (CEO) | Bought | $20.3K |
| Apr 22, 2026 | Dan Benjamin Teleman (CEO) | Bought | $10.9K |
| Mar 31, 2026 | Dan Benjamin Teleman (CEO) | Bought | $30.6K |
Who's trading NSRX
- Dan Benjamin Teleman, CEO: bought $61.8K (3 buys), last Jun 17, 2026
Get free alerts when an insider at Nasus Pharma Ltd files a new trade →